GlassScriptPhysician profile
Bethany L Mcdaniel-Vanderzwaag
NPI 1639178650
$664.29
in general payments reported to CMS, 2019-2025
18 companies · $59.71 in 2025
The $59.71 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.66 · 2020: $17.78 · 2023: $444 · 2024: $48.46 · 2025: $59.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.00 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $118.95 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $68.90 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $55.96 | 2019-2024 | Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.94 | 2023-2025 | Jardiance |
| Pfizer INC. | $46.42 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $45.40 | 2023 | Jynarque, Rexulti |
| Orthofix Medical, INC. | $41.21 | 2024-2025 | Physio-Stim |
| Radius Health, INC. | $37.56 | 2023 | Tymlos |
| Exact Sciences Corporation | $35.49 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $21.87 | 2019 | |
| Mylan Specialty L.P. | $21.10 | 2023 | Yupelri |
| Genentech USA, INC. | $20.53 | 2019 | |
| Esperion Therapeutics, INC. | $18.54 | 2023 | Nexletol |
| Novo Nordisk INC | $17.78 | 2020 | |
| Abbott Laboratories | $17.41 | 2023 | Freestyle Libre 3 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.29 | 2023 | Evkeeza |
| Ironshore Pharmaceuticals INC. | $16.06 | 2019 | |
| Lundbeck LLC | $13.88 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Mcdaniel-Vanderzwaag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.